Aptamers inhibiting the enzymatic activity of tyrosinase

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9732348
SERIAL NO

14654950

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a DNA aptamer that can inhibit the enzymatic activity of tyrosinase for the conversion of tyrosine into L-DOPA and dopaquinone, and to the dermatological and cosmetic uses thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
L V M H RECHERCHE185 AVENUE DE VERDUN SAINT JEAN DE BRAYE F-45800
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)101 RUE DE TOLBIAC PARIS 75013

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cauchard, Jean Hubert Orleans, FR 5 37
Dausse, Eric Bordeaux, FR 5 21
Kurfurst, Robin Saint Jean de Braye, FR 13 71
Schnebert, Sylvianne Olivet, FR 6 77
Toulme, Jean-Jacques Lormont, FR 5 21

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 15, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 15, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00